RN7SL16P

Across TCGA pan-cancer cohorts, RN7SL16P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RN7SL16P’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RN7SL16P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL16P is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD are the cancer types where RN7SL16P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL16P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Male	All	−0.334	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

RN7SL16P–PAAD

Open the PAAD breakdown →